A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
Actuate Therapeutics Inc.
PharmaMar
Pfizer
Actuate Therapeutics Inc.
EpicentRx, Inc.
Bayer
Merck Sharp & Dohme LLC
Leaf Vertical Inc.
Genentech, Inc.
CytoVac A/S
Hoffmann-La Roche
Adnexus, A Bristol-Myers Squibb R&D Company